文献
J-GLOBAL ID:202202249160497502
整理番号:22A0944476
ファビピラビルで治療したCOVID-19患者における尿酸上昇の危険因子の評価【JST・京大機械翻訳】
Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir
著者 (13件):
Hanai Yuki
(Department of Pharmacy, Toho University Omori Medical Center, Tokyo, Japan)
,
Hanai Yuki
(Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan)
,
Yoshizawa Sadako
(Clinical Research Center, Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan)
,
Matsuo Kazuhiro
(Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan)
,
Uekusa Shusuke
(Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan)
,
Miyazaki Taito
(Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, Japan)
,
Nishimura Koji
(Department of Pharmacy, Toho University Omori Medical Center, Tokyo, Japan)
,
Mabuchi Takumi
(Department of Pharmacy, Toho University Omori Medical Center, Tokyo, Japan)
,
Ohashi Hayato
(Department of Pharmacy, Toho University Omori Medical Center, Tokyo, Japan)
,
Ishii Yoshikazu
(Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan)
,
Tateda Kazuhiro
(Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan)
,
Yoshio Takashi
(Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan)
,
Nishizawa Kenji
(Department of Pharmacy, Toho University Omori Medical Center, Tokyo, Japan)
資料名:
Diagnostic Microbiology and Infectious Disease
(Diagnostic Microbiology and Infectious Disease)
巻:
102
号:
4
ページ:
Null
発行年:
2022年
JST資料番号:
T0019A
ISSN:
0732-8893
CODEN:
DMIDDZ
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)